#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	14910	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2112	703.0	0	.	n	.	0	C1450T	SNP	1450	1450	C	1680	1680	T	778	T,C	705,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	14910	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2112	703.0	1	SNP	n	C1184T	0	.	.	1184	1184	C	1414	1414	C	892	C,T	825,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27766	23S	2890	2890	99.93	23S.l15.c30.ctg.1	3541	781.9	0	.	n	.	0	G1337A	SNP	1337	1337	G	1721	1721	A	957	A,G	876,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27766	23S	2890	2890	99.93	23S.l15.c30.ctg.1	3541	781.9	0	.	n	.	0	T1971C	SNP	1971	1971	T	2355	2355	C	815	C	750	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27766	23S	2890	2890	99.93	23S.l15.c30.ctg.1	3541	781.9	1	SNP	n	A2045G	0	.	.	2045	2045	A	2429	2429	A	819	A,G	775,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27766	23S	2890	2890	99.93	23S.l15.c30.ctg.1	3541	781.9	1	SNP	n	C2597T	0	.	.	2597	2597	C	2981	2981	C	894	C,T	829,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
blaTEM.WHO_M_pConjugative_00003	blaTEM.WHO_M_pConjugative_00003	1	0	16	10	blaTEM	861	337	100.0	blaTEM.l6.c30.ctg.1	337	1.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Betalactam resistance
folP.WHO_O_01412c	folP.WHO_O_01412c	1	1	27	2036	folP	855	855	100.0	folP.l6.c30.ctg.1	1479	137.1	1	SNP	p	R229S	1	.	.	685	687	AGC	993	995	AGC	217;210;212	A;G;C	196;193;191	folP.WHO_O_01412c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5646	gyrA	2751	2751	99.96	gyrA.l15.c4.ctg.1	3267	172.1	1	SNP	p	S91F	1	.	.	271	273	TTC	499	501	TTC	196;197;198	T;T;C	177;177;179	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5646	gyrA	2751	2751	99.96	gyrA.l15.c4.ctg.1	3267	172.1	1	SNP	p	D95G	1	.	.	283	285	GGC	511	513	GGC	190;190;190	G;G;C	175;175;175	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5646	gyrA	2751	2751	99.96	gyrA.l15.c4.ctg.1	3267	172.1	1	SNP	p	G95N	0	.	.	283	285	GGC	511	513	GGC	190;190;190	G;G;C	175;175;175	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_X_01389	mtrR.WHO_X_01389	1	1	27	1640	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1135	143.4	1	SNP	p	G45D	0	.	.	133	135	GGC	404	406	GGC	201;197;198	G;G;C	181;177;183	mtrR.WHO_X_01389:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	888	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c30.ctg.1	905	97.7	0	.	n	.	0	A197.	DEL	197	197	A	540	540	A	223	A	208	.	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	4986	parC	2304	2304	99.87	parC.l15.c4.ctg.1	2942	169.0	0	.	p	.	0	I384V	NONSYN	1150	1152	ATC	1444	1446	GTC	212;212;212	G;T;C	200;198;196	.	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	4986	parC	2304	2304	99.87	parC.l15.c4.ctg.1	2942	169.0	1	SNP	p	D86N	0	.	.	256	258	GAC	550	552	GAC	206;205;208	G;A;C	190;185;195	parC.WHO_V_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	4986	parC	2304	2304	99.87	parC.l15.c4.ctg.1	2942	169.0	1	SNP	p	R87W	0	.	.	259	261	CGT	553	555	CGT	208;209;209	C;G;T	194;191;193	parC.WHO_V_00204c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	4986	parC	2304	2304	99.87	parC.l15.c4.ctg.1	2942	169.0	1	SNP	p	S87R	1	.	.	259	261	CGT	553	555	CGT	208;209;209	C;G;T	194;191;193	parC.WHO_V_00204c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	4986	parC	2304	2304	99.87	parC.l15.c4.ctg.1	2942	169.0	1	SNP	p	R87I	0	.	.	259	261	CGT	553	555	CGT	208;209;209	C;G;T	194;191;193	parC.WHO_V_00204c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	4986	parC	2304	2304	99.87	parC.l15.c4.ctg.1	2942	169.0	1	SNP	p	S88P	0	.	.	262	264	TCC	556	558	TCC	211;209;213	T;C;C	196;192;198	parC.WHO_V_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	539	4436	parE	1986	1986	99.95	parE.l15.c4.ctg.1	2610	169.5	0	.	p	.	0	R340C	NONSYN	1018	1020	CGC	1307	1309	TGC	194;195;196	T,C;G;C	175,1;179;176	.	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	539	4436	parE	1986	1986	99.95	parE.l15.c4.ctg.1	2610	169.5	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1517	1519	GGC	233;230;228	G;G;C	212;207;210	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.12.001	penA.12.001	1	1	27	4184	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2374	175.6	1	SNP	p	A311V	0	.	.	931	933	GCA	1249	1251	GCA	232;229;228	G;C,A;A	216;210,1;215	penA.12.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	4184	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2374	175.6	1	SNP	p	I312M	0	.	.	934	936	ATC	1252	1254	ATC	227;224;223	A;T;C	214;211;208	penA.12.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	4184	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2374	175.6	1	SNP	p	V316P	0	.	.	946	948	GTG	1264	1266	GTG	234;234;237	G;T;G	216;215;222	penA.12.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	4184	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2374	175.6	1	SNP	p	V316T	0	.	.	946	948	GTG	1264	1266	GTG	234;234;237	G;T;G	216;215;222	penA.12.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	4184	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2374	175.6	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1768	1770	ACC	218;217;220	A;C;C	195;196;201	penA.12.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	4184	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2374	175.6	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1822	1824	GCG	203;207;207	G;C;G	180;166;177	penA.12.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	4184	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2374	175.6	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1822	1824	GCG	203;207;207	G;C;G	180;166;177	penA.12.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	4184	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2374	175.6	1	SNP	p	G543S	0	.	.	1627	1629	GGC	1945	1947	GGC	200;199;198	G,A;G;C	182,1;184;181	penA.12.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	4184	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2374	175.6	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1954	1956	GGC	196;195;195	G;G;C	177;177;176	penA.12.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	4184	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2374	175.6	1	SNP	p	P552S	1	.	.	1654	1656	TCG	1972	1974	TCG	192;194;191	T,G,C;C,T;G	134,9,2;158,1;159	penA.12.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	6000	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3035	197.2	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1576	1578	CCG	196;197;196	C;C;G	176;187;177	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2284	porA	1146	1146	99.56	porA.l6.c4.ctg.1	1659	136.5	0	.	p	.	0	M83fs	FSHIFT	247	247	A	501	501	C	159	C	145	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3088	porB1b	1047	1047	99.24	porB1b.l15.c4.ctg.1	1515	202.9	0	.	p	.	0	N38E	NONSYN	112	114	AAT	376	378	GAA	250;250;252	G;A;A	231;236;237	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3088	porB1b	1047	1047	99.24	porB1b.l15.c4.ctg.1	1515	202.9	0	.	p	.	0	N134D	NONSYN	400	402	AAT	664	666	GAT	254;255;259	G;A;T	238;239;241	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3088	porB1b	1047	1047	99.24	porB1b.l15.c4.ctg.1	1515	202.9	0	.	p	.	0	P175S	NONSYN	523	525	CCA	787	789	TCA	244;242;241	T;C;A	226;227;227	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3088	porB1b	1047	1047	99.24	porB1b.l15.c4.ctg.1	1515	202.9	0	.	p	.	0	A218V	NONSYN	652	654	GCC	916	918	GTC	265;266;267	G;T;C	248;248;252	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3088	porB1b	1047	1047	99.24	porB1b.l15.c4.ctg.1	1515	202.9	0	.	p	.	0	R258H	NONSYN	772	774	CGT	1036	1038	CAT	284;284;284	C;A,G;T	265;264,1;267	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3088	porB1b	1047	1047	99.24	porB1b.l15.c4.ctg.1	1515	202.9	0	.	p	.	0	E328A	NONSYN	982	984	GAA	1246	1248	GCA	246;244;246	G;C;A	232;231;232	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3088	porB1b	1047	1047	99.24	porB1b.l15.c4.ctg.1	1515	202.9	1	SNP	p	G120K	1	.	.	358	360	AAG	622	624	AAG	249;246;247	A;A;G	235;230;230	porB1b.WHO_V_02265c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3088	porB1b	1047	1047	99.24	porB1b.l15.c4.ctg.1	1515	202.9	1	SNP	p	D121N	0	.	.	361	363	GAC	625	627	GAC	243;246;245	G;A;C	230;228;228	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3088	porB1b	1047	1047	99.24	porB1b.l15.c4.ctg.1	1515	202.9	1	SNP	p	A121D	1	.	.	361	363	GAC	625	627	GAC	243;246;245	G;A;C	230;228;228	porB1b.WHO_V_02265c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	11234	rpoB	4179	4179	100.0	rpoB.l15.c17.ctg.1	4858	231.0	1	SNP	p	H553N	1	.	.	1657	1659	AAT	2035	2037	AAT	265;267;267	A;A;T,A	252;253;254,1	rpoB.WHO_M_02157:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1124	rpsJ	312	312	100.0	rpsJ.l15.c30.ctg.1	1123	99.9	1	SNP	p	V57M	1	.	.	169	171	ATG	645	647	ATG	241;243;241	A;T;G	231;233;228	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
